<DOC>
	<DOCNO>NCT00182429</DOCNO>
	<brief_summary>What difference use one drug ( Oral Metronidazole ) versus use drug combine another drug ( Rifampin ) treatment bacteria infection-associated diarrhea patient ? This infection important cause morbidity mortality community hospital , lead cause hospital chronic facility-acquired diarrhea . Research important treatment infection . Patient care use two medication treatment regimens study .</brief_summary>
	<brief_title>Efficacy Metronidazole Versus Metronidazole Rifampin CDAD Treatment</brief_title>
	<detailed_description>Clostridium difficile infection contributes community hospital acquire morbidity mortality . Metronidazole alone usually consider drug choice , however , frequent relapse occur rate 10-40 % . The purpose study address use combine drug regimen treatment ( Metronidazole Rifampin ) treatment CDAD . These drug use together successful . Objectives determine time ( day ) resolution symptom treatment arm ; measure clinical relapse rate ; assess adverse reaction relate treatment .</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Enterocolitis</mesh_term>
	<mesh_term>Enteritis</mesh_term>
	<mesh_term>Enterocolitis , Pseudomembranous</mesh_term>
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Inpatients + outpatient diagnose CDAD base SHEA definition [ Laboratory confirmation presence C.difficile toxin use enzyme immunoassay etiology diarrhea + Presence 1 follow : diarrhea ( 6 watery stool 36 hour 3 unformed stool 24 hour least 2days ) , pseudomembranes endoscopy ] . Age &lt; 14 yr Known hypersensitivity metronidazole , rifampin Receiving medication ( ) potential significant drug interaction rifampin Active liver disease indicate ALT &gt; 200 U/L Adynamic ileus Toxic megacolon Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Antibiotic associate diarrhea</keyword>
	<keyword>C. difficile</keyword>
	<keyword>Metronidazole</keyword>
	<keyword>Rifampin</keyword>
</DOC>